PAHC vs XEL · P/E 13, rev $1.52B vs P/E 20, $39.33B cap
Phibro Animal Health Corporation (PAHC) versus Xcel Energy Inc (XEL) — a side-by-side from cached financials, not a winner call.
Phibro Animal Health Corporation (PAHC) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Xcel Energy Inc (XEL) is a utilities - regulated electric company listed on US.
Latest reported PAHC revenue for 2026-06-30 was $1.52B. Net income was $99.7M. Revenue was up 17.1% from 2025-06-30 to 2026-06-30. PAHC currently screens at market cap $1.25B and trailing P/E 13.2.
XEL does not have a complete income-statement cache yet.
PAHC currently screens at market cap $1.25B and trailing P/E 13.2. XEL currently screens at market cap $39.33B and trailing P/E 20.1.
Not investment advice. Open the PAHC and XEL stock pages for the full models.
Not investment advice.